LivaNova PLC (NASDAQ:LIVN) Receives $69.17 Average PT from Brokerages

LivaNova PLC (NASDAQ:LIVN) has been assigned an average recommendation of “Buy” from the seven analysts that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $69.17.

Several equities analysts recently commented on LIVN shares. Stifel Nicolaus increased their target price on LivaNova from $70.00 to $72.00 and gave the company a “buy” rating in a report on Thursday, July 25th. StockNews.com raised LivaNova from a “buy” rating to a “strong-buy” rating in a research report on Friday, November 8th. Needham & Company LLC reaffirmed a “buy” rating and issued a $75.00 price target on shares of LivaNova in a report on Tuesday. Robert W. Baird boosted their price objective on shares of LivaNova from $66.00 to $72.00 and gave the stock an “outperform” rating in a research report on Thursday, October 31st. Finally, The Goldman Sachs Group began coverage on shares of LivaNova in a research report on Friday, October 4th. They issued a “buy” rating and a $65.00 target price on the stock.

Hedge Funds Weigh In On LivaNova

Several institutional investors have recently added to or reduced their stakes in LIVN. Hexagon Capital Partners LLC raised its stake in shares of LivaNova by 117.8% during the second quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock worth $37,000 after purchasing an additional 370 shares during the last quarter. Fifth Third Bancorp increased its stake in shares of LivaNova by 97.1% during the second quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock worth $37,000 after acquiring an additional 332 shares during the period. Lazard Asset Management LLC purchased a new position in LivaNova during the first quarter worth about $84,000. Canada Pension Plan Investment Board acquired a new stake in LivaNova in the second quarter valued at about $88,000. Finally, Acadian Asset Management LLC purchased a new stake in LivaNova in the 1st quarter valued at approximately $94,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

LivaNova Trading Down 2.4 %

Shares of NASDAQ:LIVN opened at $52.32 on Friday. LivaNova has a 52 week low of $42.75 and a 52 week high of $64.47. The company’s 50 day moving average is $51.56 and its two-hundred day moving average is $52.98. The company has a market cap of $2.84 billion, a PE ratio of 124.57 and a beta of 1.01. The company has a current ratio of 3.37, a quick ratio of 2.87 and a debt-to-equity ratio of 0.46.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.